BSR REIT, owning 26 Class A apartment communities in Texas, trades at a 29% discount to its Q1 2026 net asset value with a 4.7% dividend yield. Market fundamentals are improving as new apartment supply in core Texas markets like Houston, Dallas, and Austin is expected to decline sharply through 2027, while demand remains strong, supporting positive rent growth. The REIT's 2025 portfolio rotation has unlocked value and positioned it for internal growth, with management targeting an increase in funds from operations per unit by 2028. Despite elevated leverage and cautious analyst sentiment, the 12–18 month price target is $14.25, implying a 26% total return, making BSR a buy opportunity.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
